Facebook Pixel tracker hidden image GLOBAL Webinars | Global Down Syndrome Foundation

GLOBAL Webinars

GLOBAL Logo

The Latest Research & Medical Care from Our Down Syndrome Experts

Stopping the Autoimmune Attack in Down Syndrome:
New Breakthroughs and Clinical Trials

Tuesday, October 1, 2024
12pm – 1:15pm MT


GLOBAL Webinars are an important benefit for our Members. Held quarterly, these 1+ hour-long webinars cover topics across the lifespan. Webinars are FREE for GLOBAL Members and $10/webinar for non-Members. If you have a family member or dear friend with Down syndrome, this webinar is for you!

In this session, Dr. Espinosa will discuss:

  • New discoveries about the harmful effects of a dysregulated immune system in Down syndrome
  • Results from an ongoing clinical trial testing the safety and efficacy of immune therapies for autoimmune disorders
  • Results from an ongoing clinical trial for Down Syndrome Regression Disorder
  • An upcoming clinical trial of an immune therapy to improve health and developmental outcomes in children with Down syndrome

Joaquín Espinosa, PhD

Dr. Espinosa is the Executive Director of the Linda Crnic Institute for Down Syndrome and Professor of Pharmacology at the University of Colorado School of Medicine. Dr. Espinosa directs a diverse research program with emphasis on Down syndrome that is supported by the NIH INCLUDE Project and the Global Down Syndrome Foundation. At the Crnic Institute, Dr. Espinosa directs the Human Trisome Project, a detailed natural history study of the population with Down syndrome, which has enabled the design of novel clinical trials to improve health outcomes in Down syndrome. Dr. Espinosa currently serves as the Leader of the Administrative and Outreach Core of the NIH INCLUDE Project Data Coordinating Center, a new data resource that aims to accelerate discoveries into the mechanisms underlying the increased risk of co-occurring medical conditions in people with Down syndrome.

Save The Date – Upcoming Webinars 

Tuesday, October 1, 2024 
Clinical Trials that Could Improve Health for People with Down Syndrome – Considerations Before you Enroll
Joaquin Espinosa, PhD

Tuesday, January 14, 2025
Cardiac Health in Down Syndrome
Arvind Hoskoppal, MD

GLOBAL Family-Friendly Guideline

The Family-Friendly version of our groundbreaking GLOBAL Medical Care Guidelines for Adults with Down Syndrome is available NOW!

GLOBAL WEBINARS – MAKING AN IMPACT

6,258

Individuals Educated

45

Expert Speakers

50

States Participated

50

Countries Reached

65,000+

Webinar Pageviews

Q&A WITH OUR EXPERTS – A VALUABLE MEMBERSHIP BENEFIT

SLEEP APNEA ACROSS THE LIFESPAN
IN PEOPLE WITH DOWN SYNDROME

Q: How does one define moderate vs severe sleep apnea? What percent in oxygen saturation during OSA episodes is the average range?

A: They are defined based on the obstructive apnea hypopnea index, which is the number of obstructive episodes during sleep divided by the hours of sleep. Many patients experience drops in oxygen saturation during obstructive episodes. These drops are variable and range from very mild to severe down to 60-70%.

DOWN SYNDROME REGRESSION DISORDER: THE LATEST RESEARCH AND PROMISING TREATMENTS

Q: What age are you seeing regression symptoms starting?

A: I think that when we’ve looked at our population level data, the mean age at onset is about 18. We see a heavy clustering in the late teen years, early twenties, and the reason why we’ve come up with this particular age range is because younger than 10, the chances that this may be autism or some other biochemical or genetic phenomenon is much higher. And similarly, over 30 is where we start to kind of bridge that gap into early onset Alzheimer’s, although that is still very young. 

Your Library of GLOBAL Webinars & Experts

Important Notice

The Global Down Syndrome Foundation’s employees and/or volunteers are NOT acting as your medical professional or attorney. Responses you receive via electronic mail, phone, or in any other manner DO NOT create or constitute a doctor-patient or attorney-client relationship between you and the Global Down Syndrome Foundation (GLOBAL), or any employee of, or other person associated with, GLOBAL.

Information received from GLOBAL’s employees or volunteers, or from this website, should NOT be considered a substitute for the advice of a medical professional or lawyer. GLOBAL DOES NOT provide any medical or legal advice. You should consult with your own doctor or lawyer for medical or legal advice. This website is a general service that provides information over the internet. The information contained on this website is general information and should not be construed as medical advice to be applied to any specific factual situations.